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Abstract
Background: Face transplantation is a surgical innovation to manage people with severely interrupted facial function and form. How
the public perceive face transplantation and its potential implications for the recipient, donor, and society is unclear. The aim of this
study was to understand the public perception of face transplantation, including when it is appropriate, what information is required
to feel adequately informed, and which factors influence a person’s willingness to donate their face.
Methods: This was a nationwide survey of participants representative of the GB public. A quantitative analysis was performed.
Free-text qualitative responses were coded with thematic content analysis and a narrative analysis was constructed.
Results: The survey included 2122 participants. Face transplantation was considered worth the potential risks if it improved an
individual’s quality of life, gave them a ‘normal life’, and/or increased their confidence and social interaction. Respondents were
worried about the impact face transplantation might have on donor families, especially recipient families adapting to the identity of
the donor. Respondents most concerned about the concept of face transplantation were aged at least 55 years (v2(4) ¼ 38.9, P< 0.001),
women (v2(1) ¼ 19.8, P < 0.001) , and Indian/Asian (v2(4) ¼ 11.9, P¼ 0.016).
Conclusion: The public perceive emotional and psychological outcomes as equally as important as, or more important than, surgical
outcomes when determining the appropriateness of face transplantation. Future research should focus on measuring and describing
emotional and psychological outcomes after face transplantation.
Introduction
The first face transplantation (FT) was reported in 2005.
Subsequently, 46 FTs have been performed globally1. As FTs become
a viable intervention for severely interrupted facial function and
form, the scientific literature is tending to focus on technical and
quantitative assessments. Efforts to understand the psychological
and quality-of-life impacts are less developed2–4. Questions about
the appropriateness of FT, and its implications for recipients and
donor families remain unresolved.
All transplants have ramifications for recipients and families,
but additional complexities relating to identity, communication,
and well-being accompany FT5,6. Although psychosocial issues
are being raised repeatedly by ethicists, the validity of qualitative
outcome measures is unclear, and recipient-centred reporting
limited7–9.
Engaging the public in FT discussions is critical because will-
ingness to donate is integral to developing a transplant service,
and because sociocultural expectations contextualize recipients’
experiences. Factors that define success, psychosocially as well
as physically, are required. Consultation with the public is also
critical to understanding of the appropriateness of FT as a high-
cost intervention in a publicly funded national health service.
The aim of this study was to undertake a nationwide survey to
determine public understanding of the circumstances in which
FT is appropriate; the most important outcome measures; infor-
mation needed to feel informed; and factors that influence will-
ingness to donate faces.
Methods
A cross-sectional survey was distributed to anonymous members
of the GB (England, Scotland, and Wales) public using the British
market research and data analytics firm, YouGovVC 10. Questions
were identified by multidisciplinary discussions between surgical
teams, psychologists, qualitative researchers, and patient repre-
sentatives. Ten priority themes were chosen and all efforts were
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made to limit order-effects bias. Participants received instruc-
tions and a short, textual description of FT, citing potential out-
comes and risks, without images.
Using a sampling algorithm that assessed eligible participants
against the project’s demographic requirements, on 24 February
2020 YouGovVC distributed the survey to participants weighted by
demographics, including age, sex, and social class. Ethnicities
were represented similarly to those of the UK population, al-
though Caucasians were slightly over-represented11.
Quantitative analysis
Analysis was performed using SPSSVR version 25 (IBM, Armonk,
New York, USA). Characteristics and proportions were compared
using the v2 test, with P 0.050 indicating significance. For non-
mutually exclusive questions, the percentage (with 95 per cent
confidence interval) based on the total in that demographic group
is provided.
Qualitative analysis
Free-text responses were aggregated and uploaded to NVivo
12TM. Thematic content analysis coded data and themes were
identified based on meanings, word choice, and context of
responses. Codes were interrogated for the frequency of themes
(N¼X, where N refers to the number of responses), co-determi-
nacy and juxtaposition, and a narrative analysis constructed.
Results
Some 2112 people responded to the survey (Table 1). Respondents
were less likely to be concerned than not concerned about FT
(v2(1) ¼ 12.0, P¼ 0.001 (Table 2). Women were more concerned
than men (v2(1) ¼ 19.8, P < 0.001). Concern was more often
expressed by respondents aged at least 55 years compared with
other age groups (v2(4) ¼ 38.9, P< 0.001), and this group more of-
ten considered FT to be never appropriate (v2(4) ¼ 10.4, P¼ 0.034).
Concern was more likely to be expressed by respondents of
Indian/Asian ethnicity (v2(4) ¼ 11.9, P¼ 0.016).
Respondents were asked to describe the circumstances in
which FT was an appropriate intervention (Table S1). Respondents
perceived FT as appropriate when disfigurements were caused by
attack, accident or condition (86 (95 per cent c.i. 84-88) per cent),
and least appropriate when caused by self-inflicted injury (45 (43-
47) per cent), particularly among respondents aged at least
55 years (36 (32-40) per cent), or of Afro-Caribbean (33 (11-55 per
cent) or Indian/Asian (19 (6-32) per cent) ethnicity. Respondents
with a facial difference agreed that FT was appropriate when psy-
chological health was affected negatively (81 (66-96) per cent),
but other groups less commonly held this view.
Narrative synthesis
Overall, 1610 participants (76 per cent) provided free-text
answers in which they centralized emotional and psychological
concerns. Potential benefits for recipients were most commonly
raised (230 participants), and FT considered worthwhile if it im-
proved quality of life (58), provided a ‘normal life’ (18) or in-
creased confidence (11). Some 109 respondents felt that potential
recipients should have autonomy in determining their needs.
Many respondents were concerned about the risk of FT; 112
felt it was too risky, and 110 highlighted dangers of rejection and
failure. Negative effects on identity and psychology (33 partici-
pants), and the trauma of facial loss for donors and families (39),
were described. Many recognized that FT required complex risk–
benefit analyses (117 participants) and, where benefits out-
weighed risks, this reflected positive psychological outcomes.
When asked what further information they required, respond-
ents stressed understanding recipient outcomes (166 partici-
pants), rates of success (78), and psychological effects (23).
Thirty-seven participants requested testimonies from transplant
recipients.
The psychological implications of FT were critical for decisions
regarding donation. When considering donation, 107 respondents
worried about the impact on their families, especially if recipients
resembled donors (68 participants), although this concept is in-
correct clinically12–14.
Seventy-two participants considered the face too personal to
donate; for this reason, 53 would not donate their face, even if
they donated other organs. Twenty-seven said this was because
the face was visible and personal, unlike internal organs. When
asked about donating the face of a loved one, despite 111 express-
ing a desire to help others, there was significant resistance.
Where people would not donate a family member’s face, this was
because the idea was upsetting, unbearable or uncomfortable
(113 participants).
Discussion
This large survey of the GB public provides new insights and lay
beliefs about FT, and how the public defines success. Emotional
and psychological outcomes were equally as important as, or
more important than, surgical outcomes. This contradicts exist-
ing literature, which largely defines the success of FT in terms of
postoperative surgical outcomes.
The importance of recipient autonomy was emphasized by
respondents, who believed FT was appropriate if recipients felt
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Personal facial difference 33 (1.5)
Family member with facial difference 60 (2.8)
Friend has facial difference 94 (4.4)
None of above 1830 (86.6)
Prefer not to say 107 (4.7)
Values in parentheses are percentages. *Sixteen respondents declined to state
ethnicity.
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that the benefits outweighed the risks. Requests for information
about aftercare, outcomes, and prognoses highlights an aware-
ness of a recipient’s longitudinal life experience, especially given
the risks of chronic rejection.
It has been argued that individuals cannot give fully informed
consent while FT remains experimental; potential recipients are
vulnerable, and long-term biopsychosocial outcomes are un-
known15–19. The present findings suggest that the emotional
needs of patients are paramount in public views of FT, and quali-
tative assessments should investigate the diverse meanings of
risk in different contexts.
One area where more clarity is needed is the relationship be-
tween cosmetic and functional repair. Respondents overwhelm-
ingly considered FT as intended to improve cosmesis, despite
being advised of functional benefits, and requested before-and-
after images20. Historically, with exceptions, FTs have been re-
served for individuals with extreme facial differences and after
reconstruction has failed. Most commonly, facial damage results
from ballistic injuries, animal attacks, burns, and diseases such
as neurofibromatosis. Current indications for FT are more com-
plex than simply cosmesis, and these complexities must form
part of organ donor education and risk evaluation for patient and
donor families21–24.
This cross-sectional survey has measured views in a snapshot
rather than over time. Response rates to some questions were
low; for example, one-third responded when asked what infor-
mation would benefit them in the future. Analyses based on low
response rates (50 or fewer responses) should be interpreted with
caution. The results may be influenced by order-effects bias.
Responses are culturally and socially situated in GB. A compara-
tive international survey is needed for generalization.
Defining and measuring emotional outcomes are paramount
in the innovation of FT. This will require patient-centred qualita-
tive analysis in combination with clinical data and international
collaboration that acknowledges diverse social and cultural con-
texts. Awareness of social prejudice also needs to be acknowl-
edged, through involvement of patient groups25,26.
Funding
This research was funded by UKRI, via the Future Leaders
Fellowship project AboutFace: The Affective and Cultural History
of Face Transplants (MR/S017356/1). The funder had no role in
the study design, data collection, analysis or interpretation, in
the writing of the report or in the decision to submit it for publi-
cation.
Acknowledgements
The authors acknowledge the guidance of the AboutFace
Advisory Board and AboutFace Lived Experience Advisory
Panel in the design of the survey; and N. Rumsey, who pro-
vided feedback on an early version of this paper. They thank
members of the Newcastle Facial Research Group for their
contribution to research design, including: P. Hodgkinson,
M. Ragbir, O. Ahmed, A. Bashir, S. Brown, M. Kennedy,
J. Adams, D. Manas, D. Sainsbury, and S. Butterworth. Data
can be made available from the corresponding author upon
reasonable request.
YouGov statement: All figures, unless otherwise stated, are from
YouGov Plc.Total sample size was 2112 adults. Fieldwork was un-
dertaken between 24 and 25 February 2020. The survey was car-
ried out online. The figures have been weighted and are
representative of all GB adults (aged 18 years and over).
D.S. reports grants and non-financial support from Stryker UK
Honorarium, personal fees from MTech consultancy, and per-
sonal fees from Sanofi Oncology. None of these are relevant to
the present study.
Disclosure. The authors declare no other conflict of interest.
Supplementary material
Supplementary material is available at BJS online.
Table 2 Association between respondent characteristics and concerns about face transplantation
No. of participants Concerned Not concerned Never appropriate
Total 801 (46) 946 (54) 155 (7.3)
Age (years)
18–24 230 (10.9) 84 (45) 104 (55) 10 (4.2)
25–34 354 (16.8) 117 (41) 171 (59) 22 (6.3)
35–44 373 (17.7) 108 (37) 181 (63) 23 (6.4)
45–54 332 (15.7) 103 (38) 166 (62) 21 (6.4)
55 823 (38.9) 388 (54) 325 (46) 79 (9.4)
Sex ratio (M : F) 1019 : 1024 342 : 459 505 : 441 86 : 69
Ethnicity
Caucasian 1968 (93.2) 736 (45) 899 (55) 130 (7.0)
Indian/Asian 62 (3.0) 31 (67) 15 (33) 8 (14.3)
Mixed race (white and other) 20 (0.9) 16 (50) 16 (50) 2 (5.7)
Afro-Caribbean 19 (0.9) 5 (33) 10 (67) 0 (0.0)
Other 27 (1.2) 11 (61) 7 (39) 5 (15.6)
Face difference relationship
Personal facial difference 33 (1.5) 15 (49) 16 (51) 2 (6.2)
Family member with facial difference 60 (2.8) 26 (49) 27 (51) 2 (3.2)
Friend has facial difference 94 (4.4) 40 (47) 45 (53) 2 (2.3)
None of above 1830 (86.6) 697 (45) 844 (55) 133 (7.3)
Prefer not to say 107 (4.7) 28 (58) 20 (42) 16 (14.7)
Values in parentheses are percentages based on respondents who indicated a preference. Participants who responded ‘don’t know’ have been omitted. Percentages
of those who said face transplant was never appropriate (never an appropriate intervention under any circumstances) are based on the total number of
participants in that subcategory. Abbreviations: F: female; M: male; No.: number
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